Polypore mushroom mycelia as an adjunct to COVID-19 vaccination: a randomized clinical trial

By afschroeder • February 1, 2026

Saxe G, Smith CN, Golshan S, Shekhtman T, Bair ZJ, Beathard C, Davis RA, MacElhern L, Shubov A, Slater D, Kao LK, Senowitz P, Wilson S. Polypore mushroom mycelia as an adjunct to COVID-19 vaccination: a randomized clinical trial. BMC Immunol. 2026 Jan 31. doi: 10.1186/s12865-026-00809-9. Epub ahead of print. PMID: 41620671.

Tags: Adjunct, Antibodies, Bird flu, Covid, fungi, General Internal Medicine, Mushroom, mycelium, Primary Care, Publications, SARS-CoV-2, side effects, vaccine

Serum Metabolite Profiles in Adults With Abdominal Obesity in Response to Consuming 1 Avocado Daily for 6 Months: An Exploratory Analysis

Matthan NR, Duscova E, Matuszek G, Zhang W, Kris-Etherton PM, Petersen KS, Rajaram S, Li Z, Reboussin DM, Sabate J, Lichtenstein AH. Serum Metabolite Profiles[...]

Perioperative Best Practices and Delirium in Patients With Cognitive Impairment

Scharp D, Meyers K, Nadkarni G, Federman A, Sarkisian C, Levin MA, Perry S, Gownivaripally P, Egorova NN, Ouyang Y, Hofer I, Vacas S. Perioperative[...]

Use of Untrained Interpreters in the Inpatient Setting: What Does the Record Show?

Linares M, Novoa-Laurentiev J, Chaitoff A, Jiang N, Ma Y, Fernández L, Zhou L. Use of Untrained Interpreters in the Inpatient Setting: What Does the[...]